Table 1.
Clinicopathological indexes | No. of patients | CAIX | ZEB1 | CD163 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Low | High | P | Low | High | P | Low | High | P | ||
Age (years) | 0.162 | 0.458 | 0.143 | |||||||
<45 | 42 | 21 | 21 | 26 | 16 | 18 | 24 | |||
≥45 | 48 | 31 | 17 | 26 | 22 | 28 | 20 | |||
FIGO stage | 0.036a | 0.022a | 0.012a | |||||||
I–IIA | 67 | 43 | 24 | 47 | 20 | 46 | 21 | |||
IIB–IV | 23 | 9 | 14 | 10 | 13 | 9 | 14 | |||
Histology | 0.369 | 0.385 | 0.832 | |||||||
High | 22 | 12 | 10 | 9 | 13 | 11 | 11 | |||
Middle | 46 | 33 | 13 | 27 | 19 | 25 | 21 | |||
Low | 22 | 14 | 8 | 12 | 10 | 13 | 9 | |||
LN metastasis | 0.030a | 0.018a | 0.019a | |||||||
Negative | 50 | 35 | 15 | 30 | 20 | 26 | 24 | |||
Positive | 40 | 19 | 21 | 14 | 26 | 11 | 29 |
LN lymph node
aStatistical significance (P < 0.05) was calculated using the Chi-squared test